SYNNEX Co. (NYSE: SNX), Auxilium Pharma (NASDAQ: AUXL), Yara International ASA (NASDAQ: YARIY), Biomarin Pharm (NASDAQ: BMRN), Virgin Media (NASDAQ: VMED), BG Group plc (NASDAQ: BRGYY) and TransMontaigne Partners L.P. (NYSE: TLP) were upgraded by analysts.
SYNNEX Co. (SNX) was upgraded by Raymond James (NYSE:RJF) from a “Market Perform” rating to an “Outperform” rating.
Auxilium Pharma (AUXL) was upgraded by Citigroup (NYSE:C) from a “Hold” rating to a “Buy” rating. They have a price target of $25.00 on the company, up from $22.00.
Yara International ASA (YARIY) was upgraded by Chardan Capital Markets from a “Neutral” rating to a “Buy” rating. They cited valuation as the catalyst behind the call.
Biomarin Pharma (BMRN) was upgraded by Deutsche Bank (NYSE:DB) to a “Buy” rating. They have a price target of $40.00 on the company, up from $27.00.
Virgin Media (VMED) was upgraded by Nomura from a “Neutral” rating to a “Buy” rating.
BG Group plc (BRGYY) was upgraded by Goldman Sachs (NYSE:GS) from a “Neutral” rating to a “Buy” rating.
TransMontaigne Partners L.P. (TLP) was upgraded by Bank of America (NYSE:BAC) from a “Neutral” rating to a “Buy” rating. They have a price target of $38.00 on the company.
No comments:
Post a Comment